Stay updated on Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The Taiwan site listing was updated from 'Taoyuan, Taiwan, 333' to 'Taoyuan City, Taiwan, 333' to clarify the precise city designation. This clarifies the recruitment location for that site within the study's geographic footprint.
    Difference
    0.0%
    Check dated 2026-05-07T22:27:51.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page footer's Revision tag has been updated from v3.5.2 to v3.5.3, representing a new build of the page without changes to the underlying study details.
    Difference
    0.0%
    Check dated 2026-04-30T17:50:53.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Updated study record dates/status entries (e.g., listing newer posted/last update timestamps and a withdrawn indicator). Removed an earlier named investigator/contact and associated role/contact/location status information.
    Difference
    0.1%
    Check dated 2026-04-23T14:49:47.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    - The page metadata now shows Revision: v3.5.2; the previous label v3.5.0 has been removed.
    Difference
    0.0%
    Check dated 2026-04-16T10:54:59.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Padova, Italy, 35128 was added and Padua, Italy, 35128 was removed from the study locations.
    Difference
    0.0%
    Check dated 2026-04-09T08:21:29.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added Naples, Italy, 20133 to the Locations list and removed Napoli, Italy, 20133.
    Difference
    0.0%
    Check dated 2026-03-25T21:22:25.000Z thumbnail image

Stay in the know with updates to Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.